<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33462636</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>NEK1 mutations and the risk of amyotrophic lateral sclerosis (ALS): a meta-analysis.</ArticleTitle><Pagination><StartPage>1277</StartPage><EndPage>1285</EndPage><MedlinePgn>1277-1285</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-020-05037-6</ELocationID><Abstract><AbstractText>Recently, NEK1 (NIMA-related kinase 1) mutations were identified as a cause of amyotrophic lateral sclerosis (ALS), but the relationship between them remains unclear owing to the small sample size and low mutation rate. We made a meta-analysis to make clear the relationship. Eight case-control studies involving 8603 cases and 18,695 controls were enrolled. Results demonstrated that the frequency of NEK1 mutations was 3.1% (95% CI 2.5-3.8%) in ALS patients, including the frequencies of loss of function (LoF) and missense mutations, which were 0.9% (95% CI 0.6-1.1%) and 2.3% (95% CI 1.7-2.8%) in ALS patients, respectively. NEK1 mutations (OR 2.14; 95% CI 1.81-2.52; p&#x2009;&lt;&#x2009;0.001), including LoF mutations (OR 6.93; 95% CI 4.38-10.96; p &lt;&#x2009;0.001) and missense mutations (OR 1.65; 95% CI 1.37-1.99; p &lt;&#x2009;0.001) were associated with a significantly increased risk for ALS. And the risk of NEK1 LoF mutations (OR 6.93) is more than four times of that of NEK1 missense mutations (OR 1.65). Subgroup analysis suggested that the frequency of LoF mutations was higher in European patients (1%) than that in Asian patients (0.7%). In conclusion, NEK1 LoF and missense mutations are low frequencies in ALS patients, but both of them are associated with the increased risk for ALS. Altogether, NEK1 mutations including LoF mutations and missense mutations are more associated with Asian patients than European patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Luqing</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Affiliated Hospital of Qingdao University, Number 16 Jiangsu Road, Qingdao, 266003, Shandong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Affiliated Hospital of Qingdao University, Number 16 Jiangsu Road, Qingdao, 266003, Shandong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Baolong</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Affiliated Hospital of Qingdao University, Number 16 Jiangsu Road, Qingdao, 266003, Shandong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Affiliated Hospital of Qingdao University, Number 16 Jiangsu Road, Qingdao, 266003, Shandong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Chang</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5351-1571</Identifier><AffiliationInfo><Affiliation>Department of Neurology, The Affiliated Hospital of Qingdao University, Number 16 Jiangsu Road, Qingdao, 266003, Shandong Province, China. zhch0532@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ZR2014HM064</GrantID><Agency>Natural Science Foundation of Shandong Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C000606914">NEK1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000072380">NIMA-Related Kinase 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072380" MajorTopicYN="N">NIMA-Related Kinase 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">NEK1 mutations</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>19</Day><Hour>5</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33462636</ArticleId><ArticleId IdType="doi">10.1007/s10072-020-05037-6</ArticleId><ArticleId IdType="pii">10.1007/s10072-020-05037-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siddique N, Siddique T (1993-2020) Amyotrophic Lateral Sclerosis Overview. Adam MP, Ardinger HH, Pagon RA, et al., (eds). GeneReviews&#xae; [Internet].&#xa0; University of Washington, Seattle</Citation></Reference><Reference><Citation>Taylor JP, Brown RH Jr, Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539(7628):197&#x2013;206</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR et al (2013) Controversies and priorities in amyotrophic lateral sclerosis. The Lancet. Neurology 12(3):310&#x2013;322</Citation><ArticleIdList><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364(6435):362</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/364362c0</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323(5918):1208&#x2013;1211</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319(5870):1668&#x2013;1672</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E et al (2013) Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol 125(4):511&#x2013;522</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1090-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Appel SH (2019) Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol 18(2):211&#x2013;220</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30394-6</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA et al (2017) Amyotrophic lateral sclerosis. Lancet 390(10107):2084&#x2013;2098</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige E et al (2006) Nek1 shares structural and functional similarities with NIMA kinase. Biochim Biophys Acta 1763(3):272&#x2013;281</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2006.01.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry AM et al (2012) Cell cycle regulation by the NEK family of protein kinases. J Cell Sci 125(Pt 19):4423&#x2013;4433</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.111195</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin P et al (2018) Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFalpha-mediated apoptosis. Proc Natl Acad Sci USA 115(26):E5944&#x2013;e5953</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1806973115</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y et al (2008) Never-in-mitosis related kinase 1 functions in DNA damage response and checkpoint control. Cell Cycle 7(20):3194&#x2013;3201</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.7.20.6815</ArticleId></ArticleIdList></Reference><Reference><Citation>Higelin J et al (2018) NEK1 loss-of-function mutation induces DNA damage accumulation in ALS patient-derived motoneurons. Stem Cell Res 30:150&#x2013;162</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2018.06.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalom O et al (2008) The mammalian Nek1 kinase is involved in primary cilium formation. FEBS Lett 582(10):1465&#x2013;1470</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2008.03.036</ArticleId></ArticleIdList></Reference><Reference><Citation>White MC, Quarmby LM (2008) The NIMA-family kinase, Nek1 affects the stability of centrosomes and ciliogenesis. BMC Cell Biol 9:29</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2121-9-29</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET et al (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347(6229):1436&#x2013;1441</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId></ArticleIdList></Reference><Reference><Citation>Edens BM, Miller N, Ma YC (2016) Impaired Autophagy and Defective Mitochondrial Function: Converging Paths on the Road to Motor Neuron Degeneration. Front Cell Neurosci 10:44</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00044</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna KP et al (2016) NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet 48(9):1037&#x2013;1042</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3626</ArticleId></ArticleIdList></Reference><Reference><Citation>Gratten J et al (2017) Whole-exome sequencing in amyotrophic lateral sclerosis suggests NEK1 is a risk gene in Chinese. Genome Med 9(1):97</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-017-0487-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D et al (2016) NEK1 mutations in familial amyotrophic lateral sclerosis. Brain 139:CP14&#x2013;CP17</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww033</ArticleId></ArticleIdList></Reference><Reference><Citation>Black HA et al (2017) Genetic epidemiology of motor neuron disease-associated variants in the Scottish population. Neurobiol Aging 51:178.e11&#x2013;178.e20</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.12.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP et al (2018) NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients. Neurobiol Aging 61:255.e1&#x2013;255.e7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.08.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu S et al (2018) Mutation screening of NEK1 in Chinese ALS patients. Neurobiol Aging 71:267.e1&#x2013;267.e4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.06.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603&#x2013;605</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-010-9491-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruse H, Ishiura H, Mitsui J et al (2020) Loss-of-function variants in NEK1 are associated with an increased risk of sporadic ALS in the Japanese population. J Hum Genet. https://doi.org/10.1038/s10038-020-00830-9</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>